1. Tyrer JH, Sutherland JM, Hooper WD (1970) Outbrake of anticonvulsant intoxication in an Australian city. Br Med J 4: 271?273
2. Linderbaum V, Mellow HM, Blackstone MD, Butter VP (1971) Variation in biological availability of digoxin from four preparations. N Engl J Med 285: 1344
3. Department of Health Education and Welfare, Food and Drug Administration (1977) Drug products. Bioequivalence requirements and in-vivo bioavailability procedures. Fed Reg, Part III 42: 1624?1653
4. National Board of Health and Welfare (Sweden). Appendix to the Code of Statutes (1980) Registration of pharmaceutical specialities. Instructions for submission of applications (SOSFS (M) 90: 49?56
5. Westlake WJ (1973) Dosage form and bioavailability. In: Swarbrick J (ed) Current concepts in the pharmaceutical science. Lea and Febiger, Philadelphia 149?179